Naesström, Matilda http://orcid.org/0000-0001-9679-1609
Johansson, Johannes
Hariz, Marwan
Bodlund, Owe
Wårdell, Karin
Blomstedt, Patric
Funding for this research was provided by:
Swedish Research Council (2016-03564)
Swedish Foundation for Strategic Research (BD15-0032)
Umea University
Article History
Received: 7 May 2021
Accepted: 26 August 2021
First Online: 15 October 2021
Change Date: 24 February 2022
Change Type: Update
Change Details: The original version of this paper was updated to add the missing compact agreement Open Access funding note.
Declarations
:
: The study protocol was approved by the Ethical Committee of Umea University (No. 08-090 M), and written informed consent was obtained from participants according to the Declaration of Helsinki.
: Informed consent was obtained from all participants included in the study.
: Matilda Naesström, Johannes Johansson, and Owe Bodlund have no conflict of interest.Karin Wårdell is a shareholder in FluoLink AB.Patric Blomstedt is a consultant for Abbott, Boston Scientific, and Medtronic and a shareholder in Mithridaticum AB.Marwan Hariz received lecturing fees from Boston Scientific.